228 related articles for article (PubMed ID: 28639741)
1. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Gregersen H; Vangsted AJ; Abildgaard N; Andersen NF; Pedersen RS; Frølund UC; Helleberg C; Broch B; Pedersen PT; Gimsing P; Klausen TW
Cancer Med; 2017 Jul; 6(7):1807-1816. PubMed ID: 28639741
[TBL] [Abstract][Full Text] [Related]
2. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study.
Sørrig R; Klausen TW; Salomo M; Vangsted A; Gimsing P
Eur J Haematol; 2019 Feb; 102(2):182-190. PubMed ID: 30485563
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
5. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
[TBL] [Abstract][Full Text] [Related]
6. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
7. Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group.
Johnsen HE; Klausen TW; Boegsted M; Lenhoff S; Gimsing P; Christiansen I; Gedde-Dahl T; Lindås R; Mellqvist UH;
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):290-6. PubMed ID: 20709667
[TBL] [Abstract][Full Text] [Related]
8. Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014.
Helm-Petersen S; Sørrig R; Klausen TW; Preiss B; Frølund UC; Helleberg C; Breinholt M; Andersen MK; Abildgaard N; Gimsing P; Vangsted AJ
Leukemia; 2018 Sep; 32(9):2054-2057. PubMed ID: 29500392
[No Abstract] [Full Text] [Related]
9. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.
Engelhardt M; Domm AS; Dold SM; Ihorst G; Reinhardt H; Zober A; Hieke S; Baayen C; Müller SJ; Einsele H; Sonneveld P; Landgren O; Schumacher M; Wäsch R
Haematologica; 2017 May; 102(5):910-921. PubMed ID: 28154088
[TBL] [Abstract][Full Text] [Related]
10. Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.
Rodriguez TE; Hari P; Stiff PJ; Smith SE; Sterrenberg D; Vesole DH
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1391-1396. PubMed ID: 27164062
[TBL] [Abstract][Full Text] [Related]
11. Community-acquired Staphylococcus aureus bacteremia: Studies of risk and prognosis with special attention to diabetes mellitus and chronic heart failure.
Smit J
Dan Med J; 2017 May; 64(5):. PubMed ID: 28552097
[TBL] [Abstract][Full Text] [Related]
12. Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients.
Ríos-Tamayo R; Sáinz J; Martínez-López J; Puerta JM; Chang DY; Rodríguez T; Garrido P; de Veas JL; Romero A; Moratalla L; López-Fernández E; González PA; Sánchez MJ; Jiménez-Moleón JJ; Jurado M; Lahuerta JJ
Am J Hematol; 2016 Jul; 91(7):700-4. PubMed ID: 27074204
[TBL] [Abstract][Full Text] [Related]
13. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
[TBL] [Abstract][Full Text] [Related]
14. Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
Sørrig R; Klausen TW; Salomo M; Vangsted AJ; Østergaard B; Gregersen H; Frølund UC; Andersen NF; Helleberg C; Andersen KT; Pedersen RS; Pedersen P; Abildgaard N; Gimsing P;
Eur J Haematol; 2016 Sep; 97(3):303-9. PubMed ID: 26710662
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of patients with multiple myeloma treated with total body irradiation-Melphalan conditioning.
Munker R; Baghian A; Koleva Y; Andrews P; Matharoo GS; Wright AE; Saba NS; Weiner RS; Safah H
Eur J Haematol; 2017 Jul; 99(1):56-59. PubMed ID: 28370630
[TBL] [Abstract][Full Text] [Related]
16. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
[TBL] [Abstract][Full Text] [Related]
17. Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Blanes M; Lahuerta JJ; González JD; Ribas P; Solano C; Alegre A; Bladé J; San Miguel JF; Sanz MA; de la Rubia J
Biol Blood Marrow Transplant; 2013 Jan; 19(1):69-74. PubMed ID: 22897964
[TBL] [Abstract][Full Text] [Related]
18. Long-term mortality in patients diagnosed with pneumococcal meningitis: a Danish nationwide cohort study.
Roed C; Engsig FN; Omland LH; Skinhoj P; Obel N
Am J Epidemiol; 2010 Aug; 172(3):309-17. PubMed ID: 20573837
[TBL] [Abstract][Full Text] [Related]
19. The impact of comorbidity on mortality in Danish sarcoma patients from 2000-2013: A nationwide population-based multicentre study.
Raedkjaer M; Maretty-Kongstad K; Baad-Hansen T; Jørgensen PH; Safwat A; Vedsted P; Petersen MM; Hovgaard T; Nymark T; Keller J
PLoS One; 2018; 13(6):e0198933. PubMed ID: 29889880
[TBL] [Abstract][Full Text] [Related]
20. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]